Selective estrogen receptor modulators (SERM) for the brain: Recent advances and remaining challenges for developing a NeuroSERM?

This publication has 82 references indexed in Scilit:

• Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells
  Nutrition and Cancer, 1997
• Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cellsin vitro
  Nutrition and Cancer, 1997
• Characteristics of a membrane-associated antilactogen binding site for tamoxifen
  Molecular and Cellular Endocrinology, 1993
• A Risk-Benefit Assessment of Tamoxifen Therapy
  Drug Safety, 1993
• Droloxifene, a new anti-oestrogen in postmenopausal advanced breast cancer: Preliminary results of a double-blind dose-finding phase II trial
  European Journal Of Cancer, 1992
• Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle
  European Journal of Cancer and Clinical Oncology, 1983
• Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: Problems and potential for future clinical applications
  Breast Cancer Research and Treatment, 1983
• Oestrogen-responsive human breast cancer in long term tissue culture
  Nature, 1975
• Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptor
  Published by Elsevier ,1975
• A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474
  British Journal of Cancer, 1971